The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent. The Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
- Mohler III, E.R.
- Ballantyne, C.M.
- Davidson, M.H.
- Hanefeld, M.
- Ruilope, L.M.
- Johnson, J.L.
- Zalewski, A.
ISSN: 0735-1097
Any de publicació: 2008
Volum: 51
Número: 17
Pàgines: 1632-1641
Tipus: Article